Adarx Pharmaceuticals, Inc.
Clinical trials sponsored by Adarx Pharmaceuticals, Inc., explained in plain language.
-
New hope for swelling disorder: experimental drug enters human trials
Disease control OngoingThis study tests an experimental drug called ADX-324 for hereditary angioedema, a genetic condition that causes sudden, severe swelling attacks. The first part involves healthy volunteers to check safety, and the second part includes people with the disease to see how the drug wo…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New blood pressure drug ADX-850 enters first human tests
Disease control OngoingThis early-stage study tests a new medicine called ADX-850 in 28 adults with mild to moderate high blood pressure. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure changes in blood pressure over time.
Phase: PHASE1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC